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Highlights 
 Orthodox fasting (OF) is a periodical vegetarian subset of the Mediterranean 
diet 
 We evaluated OF effects in general population fasters (GF) and Athonian 
monks (AM) 
 AM demonstrated lower BMI, Body Fat Mass and HOMA-IR values 
compared to GF 
 The results highlight the unique characteristics of Athonian OF as a health-
promoting diet 
 Limitation of specific vitamins and minerals during OF warrants further 
investigation 
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Abstract 
Objective: Christian Orthodox fasting (COF), a periodical vegetarian subset of the 
Mediterranean diet, has been proven to exert beneficial effects on human health. 
Athonian fasting is a pescetarian COF variation, where red meat is strictly restricted 
throughout the year. Previous studies have examined the COF nutritional synthesis 
and health impact in general population fasters (GF) and Athonian monks (AM), 
separately. This is the first study to comparatively evaluate the characteristics and 
effects of this nutritional advocacy between the two populations.  
Methods: 43 general population male fasters (aged 20-45 years) and 57 age-matched 
male monks following COF were included in the study. Dietary intake data were 
collected in both groups during a restrictive (RD) and a non-restrictive (NRD) day. 
Nutritional, cardiometabolic and anthropometric parameters were compared between 
the two cohorts. 
Results: AM compared to GF, presented lower daily total caloric intake for both 
RD(1362.42±84.52 vs 1575.47±285.96 kcal, p<.001) and NRD (1571.55±81.07 
vs2137.80±470.84kcal, p<.001).They also demonstrated lower Body Mass Index 
(23.77±3.91 vs 28.92±4.50 kg/m
2
, p<.001), Body Fat mass (14.57±8.98 vs 
24.61±11.18 kg, p=.001) and Homeostatic Model Assessment for Insulin Resistance 
values(0.98±0.72 vs 2.67±2.19 mmol/l, p<.001),compared to GF. Secondary 
hyperparathyroidism (Parathyroid Hormone concentrations:116.08±49.74 pg/ml),as a 
result of profound hypovitaminosis D[25(OH)D: 9.27±5.81 ng/ml], was evident in the 
AM group.  
Conclusions: The results of the present study highlight the unique characteristics of 
Athonian fasting and its value as a health-promoting diet. The impact of limitation of 
specific vitamins and minerals during fasting warrants further investigation. 
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Introduction 
Previous research [1-4], has indicated the Mediterranean diet (MD) as an ideal dietary 
paradigm for the prevention of cardiovascular and degenerative diseases [5-9]. 
Several studies [10-14] attested emerging roles for a subset of the MD, the Greek 
Orthodox fasting ritual, which - for religious reasons - is considered to be deeply 
integrated in the dietary behaviour of the Greek population [11-13].  
Christian Orthodox fasting (COF) is adopted as the predominant, traditional dietary 
pattern for a large part of the Greek Orthodox population for prolonged periods (from 
120 to 180 days) annually [8].COF has been suggested to share the beneficial effects 
of the typical MD by promoting specific cardio-protective mechanisms, including 
reduced intake of dietary cholesterol, fatty acids and optimal effects on plasma lipid 
concentrations[15]. It typically integrates parameters of dietary restriction of specific 
macronutrients, given that it suggests abstinence from meat, dairy products and eggs 
daily, and from fish and olive oil on specific weekdays, during fasting periods [8]. In 
addition, most existing data [11-16] indicate that restricted caloric intake is evident 
during COF periods, accentuating COF as a unique component of both caloric and 
dietary restriction regimen, among the other well-investigated religious motivated 
dietary models [10,11]. 
A considerable number of previous studies [8,11-16]have focused on the nutritional 
aspects of COF as practiced by the general Orthodox population, reporting interesting 
data on this obscured but still vital, subtype of theMD. This dietary pattern, inducted 
by the Greek Orthodox Church as a way of spiritual prosperity for the faithful [8], was 
initially followed by the Greek Orthodox monks, comprising the main nutritional 
model of the monasterial community of Mount Athos. The autonomous monasterial 
state of Mount Athos located in Halkidiki, Northern Greece, is the largest Greek 
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monasterial community and a major centre of Eastern Orthodox monasticism [11]. A 
total population of approximately 1800 male monks is residing in twenty different 
monasteries, following a strict dietary and physical activity daily plan, incorporated 
into their religious duties. Athonian COF can be described as a pescetarian variation 
of the typical COF, meaning that red meat consumption is totally restricted throughout 
the year, during both fasting and non-fasting periods.  
The present study attempted to comparatively evaluate COF, as practiced by two 
distinct populations: the Orthodox monks in Mount Athos who strictly adhere to 
fasting, and a cohort of general population in central Northern Greece, practicing 
fasting rituals from early adulthood as periodical fasters, with a discourse on: i) the 
similarities and differences in practicing COF between the two cohorts and ii) the 
comparative evaluation of the nutritional synthesis in each cohort according to 
recommended dietary intakes suggested by international health organizations, in the 
context of a health promoting diet. 
 
Methods 
Study population  
Study recruitment included a total of 43 Christian orthodox male adults (Group 1), 
aged 20-45 years, residing in the region of Chalkidiki, Northern Greece and an age-
matched cohort of57Orthodox male Athonian monks (AM), from the monasterial 
community of Mount Athos (Group 2).Individuals with at least 6 months of adherence 
to COF were included in the study. Subjects with chronic diseases, receiving 
medication and/or vitamin or mineral supplements were excluded. Inclusion and 
exclusion criteria for the recruitment of participants in the present study have been 
previously described in detail [11]. 
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Study design 
Dietary analysis 
Dietary intakes were analysed during two days of COF: a day during a weekend of 
Nativity Fast, where fish, olive oil, cereals, legumes, nuts, vegetables, fruits and 
alcohol are allowed, defined as ‘non-restrictive day' (NRD), and a weekday during 
Great Lent, where olive oil and fish are additionally excluded from the regular 
nutritional plan, named as restrictive day (RD). We followed this categorization for 
both study groups, as previously reported [11].  
Consumption of food and beverages was self-recorded by the participants using a 24 h 
dietary recall and subsequently confirmed by a dietician. The accuracy of estimation 
of portion sizes was based on standardized photo albums [17-19]. The protocol 
followed for the dietary analysis has been previously described [11] and was based on 
data derived from the Food Processor Nutrition Analysis Reports software, adhering 
to US dietary guidelines [20], the Hellenic Health Foundation [21] and the US 
Recommended Dietary Allowance (RDA) / Recommended Daily Intake (DRI) values 
[22].Percentage total energy intake (% TEI) was calculated using conversion factors 
of 4,4 and 9kcals/gram respectively for carbohydrates, protein and fat [23].  
 
Anthropometric measurements and biochemical analysis 
Anthropometric measurements and biochemical analyses were performed in both 
groups using standardised procedures. Exact methods, reference ranges, equipment 
used and other details have been previously analytically described [11]. In brief, Body 
Weight (BW) was recorded to the nearest 0.01 kg using a calibrated computerized 
digital balance (K-Tron P1-SR, USA Onrion IIc); each participant was barefoot and 
lightly dressed during measurement.  The Body Mass Index (BMI) was calculated as 
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the ratio of weight in kilograms divided by the height in metres squared (kg/m
2
) [24]. 
Body Fat (BF) mass and percentage, Visceral Fat (VF), Muscle Mass (MM), Fat-free 
Mass (FFM) and Total Body Water (TBW) were measured using bioelectrical 
impedance analysis (BIA) (SC-330 S, Tanita Corporation, Tokyo) [25].Insulin 
resistance was calculated using the homeostasis model assessment (HOMA-IR) 
formula described by Matthews et al [26] as follows: [(FPI (µU/ml) X FPG 
(mmol/L)/22.5].  
 
Ethical considerations  
The study was conducted in accordance with the Declaration of Helsinki on the 
human trial performance. Written informed consent for inclusion in the study was 
given by participants. Official written approval for the inclusion of the AM group was 
given by the Holy Supervision Council composed of representatives from all 20 
monasteries of Mount Athos, after submission of the full study protocol 12 months 
prior to study initiation (Constitutive Chart of Mount Athos –Greek Constitution 
1975/86 art. 105 & 1-5). 
 
Statistical analysis 
Paired samples t-test was used to compare dietary and nutrient intake on RD and 
NRD. Dietary and nutrient intake on RD and NRD between groups (lay people 
sample vs. monks) was compared using independent sample t-test. Comparing dietary 
intake as percentages were calculated using Mann-Whitney U test for between-group 
analyses, and Wilcoxon signed-rank test for within-group analyses. For the ease of 
interpretation and facilitating meta-analysis in the future, group statistics are reported 
as means and standard deviation, even when nonparametric statistics were used to test 
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for statistical significance between the two groups. Following the recommended 
reporting guidelines for medical and behavioural research [27], means and standard 
deviations were provided for all comparisons and respective effect sizes (Cohen’s d) 
were reported for all statistical tests. Effect sizes were discussed in both theoretical 
and practical implications according to the recommended reference values [28,29]. 
Level of significance was defined as p < .05 (non-directional) for all statistical tests. 
Data analyses were performed using SPSS v25. Effect sizes were calculated using the 
online meta-analysis effect size calculators [30,31], with Morris and De Shon's 
correction (Eq8) for paired sample comparison [32]. 
 
Results 
Demographic and anthropometric population characteristics are shown in Table 
1.Participants in Group 1 (GF) adhered to COF periodical patterns from early 
adulthood (mean duration: 19.2±4.5 years).The monks group adhered to religious 
fasting continually, since the beginning of their monastic life (mean duration: 
13.27±8.9 years).Median BMI and %of BF values in Group 1 were above the optimal 
range (28.92±4.5 kg/m
2
 and 26.04±8.18 %respectively). Group 2 demonstrated 
significantly lower BMI (23.77±3.91 vs 28.92±4.50, p<.001), BF mass (14.57±8.98 vs 
24.61±11.18 kg, p=.001), Waist Circumference values (83.26±4.23 vs 94.32±3.32 cm, 
p<.001),and VF mass (7.08±4.50 vs 13.49±5.87 kg,p<.001) compared to Group 1.  
 
Comparison of dietary and nutrient intake in fasting- and non-fasting days 
Group 1 (General population fasters) 
Table 2 presents macronutrient and micronutrient intake on RD and NRD for Group 
1. A key finding was that daily energy intake was considerably lower on RD 
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compared to NRD (1575.5±285.96vs2137.8±470.84kcal respectively; p<.001). Fat 
intake was lower during RD compared with NRD (54.94±26.92 vs104.59±31.22 g 
respectively; p<.001). Total fat intake [% total energy intake (TEI)] differed 
significantly between RD and NRD (31.0±13.71 vs44.58±9.23% respectively; 
p=.002).Protein intake was higher on NRD, compared to RD 
(98.01±21.81vs48.58±15.98 g respectively; p<.001). Overall, macronutrient 
consumption during RD comprised of 59.9% carbohydrates, 31% fat and 12.4% 
protein and 32.97%, 44.58%and18.79% on NRD, respectively. The levels of intake of 
vitamins D and E and minerals (Ca, Mg, and K) were below the recommended DRI, 
during both RD and NRD [21,22]. Intake of Fe [165.43±60.20 (RD) and 
135.47±46.99 (NRD) % DRI, p=.101] and vitamin C [199.79±156.66 (RD) and 
173.41±157.77 (NRD) % DRI, p=.605]was adequate, despite the restriction of meat 
products during fasting periods. Of major interest, vitamin D intake was very low 
during both RD and NRD (11.97±21.78vs60.36±77.38% DRI respectively; p=.001).   
 
Group 2 (Athonian Monks) 
Table 3 presents macronutrient and micronutrient intake on RD and NRD for AM.  
We found that daily energy intake was low on NRD and even lower on RD 
(1571.55±81.07vs1362.42±84.52kcal respectively; p<.001). Fat intake was lower 
during NRD compared to RD (21.47±1.96 vs30.07±0.17g respectively; p<.001). Total 
fat intake (% TEI) was low during both RD and NRD (19.93±1.09 vs12.28±0.63% 
respectively; p<.001). Protein intake was higher on RD, compared to NRD both in 
absolute terms (89.24±1.38vs72.35±1.32g respectively; p<.001) and as a % of TEI 
(26.28±1.19 vs 18.47±0.56% respectively; p<.001). Overall, macronutrient 
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consumption during RD comprised 46.64% carbohydrates, 19.93% fat and 26.28% 
protein and 74.95%, 12.28% and 18.47% on NRD, respectively. 
The levels of intake of vitamins A, B2, D and minerals (Ca, Mg, Na) were also below 
the recommended % of DRI during both RD and NRD [21,22].Remarkably, vitamin 
D intake was very low during both RD and NRD (20.00±0.0 vs 19.60±0.0 % DRI 
respectively).  In contrast, although meat consumption is totally restricted in Athonian 
COF, intake of vitamin B12 was adequate during both RD and NRD (229.17±0.0 vs 
233.33±0.0 % DRI respectively),as was the intake of vitamin C (429.04±622.79 
vs622.79±4.79 % DRI respectively; p<.001) and Fe (137.00±0.0 vs181.30±0.60 % 
DRI respectively; p<.001).  
 
Comparison of dietary and nutrient intake in fasting- and non-fasting days 
between groups 
Restrictive day 
Table 4 presents macronutrient and micronutrient intake on RD in the two groups. A 
notable finding was that daily energy intake was considerably lower on RD in Group 
2 compared to Group 1(1362.42±84.52 vs1575.47±285.96kcal respectively; p<.001).  
Carbohydrate and fat intake were higher in Group 1 (GF) compared to Group 2 (AM) 
(235.20±71.49 vs159.60±21.82 g respectively; p<.001 and 54.94±26.92 vs30.07±0.18 
g respectively; p<.001),whereas protein intake was higher on RD in Group 2 
compared to Group 1 (89.24±1.38 vs48.58±15.99 g respectively; p<.001).Total fat 
intake (%TEI) was significantly higher in Group 1 than in Group 2 (30.5±15.0 
vs19.93±1.09% respectively; p<.001).Overall, macronutrient consumption during RD 
for Group 1 and 2included 60.3% carbohydrates,30.5% fat and 12.5% protein and 
46.64%, 19.93%and 26.28%, respectively. 
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Saturated fat intake was low in both Groups 1 and 2 (10.36±8.13vs 12.75±0.00 g 
respectively; p=.015),whereas cholesterol intake was higher in Group 2 compared to 
Group 1(181.00±0.00 vs64.04±145.90 mg respectively; p<.001). 
The levels of intake of many vitamins (C,D and E) and minerals (Ca, Fe, Mg) 
significantly differed between the two groups. In specific, vitamin C and B12 intake 
was 2 to 3–fold higher in Group 2 compared to Group 1 (257.54±2.99 
vs119.88±94.00mcg respectively; p<.001and 5.50±0.00 vs 1.06±1.63 mcg, 
respectively; p<.001).On the other hand, in both groups mineral intake (Ca, Mg, 
Na,K) were below the recommended % of DRI [21,22]. 
 
Non-restrictive day 
Table 5 presents macronutrient and micronutrient intake on NRD for both groups. 
Daily energy intake was considerably lower in Group 2 compared to Group 
1(1571.55±81.07 vs2137.80±470.84kcal respectively; p<.001). Carbohydrate intake 
was notably higher in Group 2 than in Group 1both in terms of absolute intake 
(294.35±23.40 vs176.63±51.19 g respectively; p<.001),and as a % TEI (74.95±2.43 
vs 33.39±6.03 respectively; p<.001). Fat and protein intakes were higher in Group 1 
compared to Group 2 (104.59±31.22 vs21.47±1.96 g respectively; p<.001and 
98.01±21.81 vs72.35±1.32 g respectively; p<.001). 
Overall, macronutrient consumption during NRD comprised of 33.39% 
carbohydrates, 43.95% fat and 18.84% protein for Group 1 and 74.95%, 12.28% and 
18.47%, respectively for Group 2.Saturated fat and cholesterol intake was higher in 
Group 1 than in Group 2 (34.97±14.70vs16.40±0.0 g respectively; p<.001and 
372.21±175.25vs178.00±0.00 mg respectively; p<.001).The levels of intake of Mg 
and Ca, were below the recommended % of DRI [21,22] for both groups, whereas Na 
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intake was markedly lower for Group 2 compared to Group 1 (1549.00±0.00 vs 
3224.33±1184.78 mg respectively; p<.001).Intake of vitamin B12 was adequate for 
both Groups 1 and 2(231.18 vs 233.3 % DRI respectively; p=.040), as was the intake 
of vitamin C (176.98 vs 622.78% DRI respectively; p<.001) and Fe (135.83 vs 181.3 
% DRI, respectively; p<.001). 
 
Cardiometabolic parameters 
Table 6 shows the cardiometabolic markers of the two groups. In detail, Groups 1 and 
2 demonstrated a comparable profile for Total Cholesterol (TC)(189.1±45.08vs 
183.00±40.87 mg/dl respectively; p=.470) and Low-Density Lipoprotein (LDL-
C)(120.68±45.92vs119.97±36.70mg/dl respectively; p=.930), while High-Density 
Lipoprotein (HDL-C) concentrations were in the low–normal range for both 
(43.20±11.05vs 47.83±14.11 mg/dl respectively; p=.061).Regarding glucose 
homeostasis, Group 2 demonstrated a more favourable profile on fasting insulin 
concentrations and Homeostatic Model Assessment for Insulin Resistance (HOMA-
IR) values, compared to general population (4.61±3.16vs11.64±9.21 μU/ml 
respectively; p<.001 and 0.98±0.72 vs2.67±2.19 mmol/l respectively; p<.001). 
Concerning calcium homeostasis, Parathyroid Hormone (PTH) was found to be 
significantly elevated in the monks group (116.09±49.75pg/ml), while serum calcium 
was within the normal range (9.06±0.42 mg/dl). It is worth pointing out that all monks 
were vitamin D deficient [25(OH) D levels 9.275.81ng/ml].  
 
Discussion 
This study is the first comparative report in the literature of dietary intake, 
anthropometric and cardiometabolic markers in two distinct groups of Orthodox 
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fasters, monks and general population. Significant differences in nutritional patterns 
between RD and NRD were evident between the two groups, in conjunction with a 
more favourable profile of anthropometric and glucose homeostasis in the AM group 
compared to the general population, with the exception of profound hypovitaminosis 
D. 
The daily, Recommended Energy Intake (REI) is individualized and dependent on a 
variety of factors, such as age, sex and physical activity, among others. However, it 
could be estimated that the mean energy intakes of 1362.4and 1567.6 kcal that monks 
consume during a RD and NRD respectively, correspond to approximately46.5% and 
53.5% of the daily, REI for a moderately active male, aged between 20 and 45 years, 
according to recommendations [22]. On the other hand, general fasters’ mean energy 
intakes during a RD and NRD account for about 53.5% and 72.3% of the REI, 
respectively.  
  Caloric restriction has been described as an important characteristic of COF [10, 
11].According to the results of the present study,caloric intake was lower during RD 
compared to NRD in both groups, whereas AM demonstrated significantly lower total 
caloric intake for both days. This phenomenon was probably the result of their strict 
adherence to the traditional Athonian dietary pattern, including only two main 
mealsdaily, compared to the typical COF followed by the general Orthodox 
population. Dietary temperance is considered to be a primaryelement of the Athonian 
lifestyle and nutritional behavior [10,11].There is growing evidence connecting 
caloric restriction to significant health benefits through a variety of mechanisms, such 
as activation of cellular stress response elements, increased autophagy, adjustment of 
apoptosis and changes in hormonal environment [33]. 
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 Notable nutrient intake differences were also evident among study groups on both 
RD and NRD. General population demonstrated an increased intake of 
carbohydrates(60.3%) and fat (30.5%) during RD compared to AM (46.64% and 
19.93%, respectively).A higher fat intake compared to AM was also evident during 
NRD, as well (43.95% vs 12.28%, respectively).As previously demonstrated [11], 
Athonian fasting is characterized by a remarkable restraint of total fat intake, 
compared to the traditional MD pattern followed by the general population included 
in this analysis, which comprises a 37-40% of TEI as fat,mostly from fish and plant 
sources[5-7,21,34]. 
  Dietary protein and fat intake during COF in Athos is mainly from fish, olive oil, 
dairy products and seeds, given that meat consumption is forbidden and legumes, 
fruits, beans and nuts are the principal food alternatives [8,11].This nutritional model 
has been reported to provide an increased intake of monounsatured fatty acids 
(MUFA) and n-6 and n-3 polyunsaturated fatty acids (PUFA). It is now recognized 
that MUFAs found in extra virgin olive oil used as the only source of dietary oil in 
Athos[10,11], and n-3 PUFA mainly obtained from fish, contribute to the beneficial 
effects of the MD, as previously reported in studies of Crete’s population[5,12,13].] 
As previously described [35], there are important differences between the 
Mediterranean and Western diets, not only regarding the quantity and sources of 
MUFA, but also in the quantity of n-6 and n-3PUFA. Results of the PREDIMED trial 
[36] demonstrated that a typical MD - although of relatively high fat intake (35–40%) 
compared to the nutritional model suggested from the American Heart Association 
(AHA) guidelines [37] for preventing cardiovascular disease (CVD) –was positively 
associated with primary CVD prevention. These observations raised concerns[38] 
about recommending a low-fat diet, which coupled with the widespread availability of 
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zero- or low-fat foods, could actually favour higher consumption of refined starch-and 
sugar-rich foods, thus contributing to excessive energy intakes. In support of this 
concern, there is some evidence that both MUFA and PUFA in the Mediterranean 
eating pattern tend to reduce LDL-C and TG, while increasing HDL-C [11, 
39].Moreover, with the exception of a 3-fold increase during NRD compared with RD 
in the general population, consumption of saturated fat was remarkably lower 
compared to typical Northern Europe and Western population eating patterns[35-37]. 
   Lipid and glucose profiles were optimal for the majority of included subjects and 
consistent with recommendations [37].However, HDL-C concentrations were in the 
lower normal range, a finding previously described with consumption of low calorie 
and vegetarian diets[40].AM demonstrated a favourable glucose homeostasis profile 
compared to general population fasters, despite the fact that they consume a 
remarkable amount of carbohydrates (74.95 % TEI), during NRD. In particular, 
markers for insulin resistance were significantly lower in monks compared with lay 
people, using HOMA-IR [24]. Although fasting glucose concentrations were 
significantly lower in monks compared with lay fasters (4.71±0.60 vs 5.12±0.32 
mmol/L respectively; p<.001), fasting insulin concentrations were almost threefold 
lower in monks (4.61±3.16 vs 11.64±9.21 µg/ml respectively; p<.001). Fasting insulin 
levels have been shown to highly correlate with HOMA-IR measurements [41]. This 
lower insulin resistance in the monks is highly favourable, since insulin resistance has 
been proposed as a central mediator of several non-communicable diseases 
characterised by chronic inflammation [42-46]. The lower insulin resistance seen in 
the monks is likely to relate to their lower BMI, BF and VF compared with the lay 
sample (Table 1), combined with increased physical activity incorporated into their 
daily schedule. Visceral adiposity is associated with metabolic abnormalities 
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including insulin resistance, abnormal blood lipids and non-alcoholic fatty liver 
disease [44]. It is of interest that the periodic fasting of lay people did not appear to 
protect them from overweight or from relatively higher visceral fat compared with 
monks (Table 1). Periodic fasting such as that proposed by popular diets (e.g. 5:2 
diet) is advocated as an alternative to continuous energy restriction for weight 
management [47,48], with the potential to improve metabolic biomarkers [6,9,49]. 
However, the impact on clinical outcomes such as Alzheimer’s disease, diabetes, 
cardiovascular disease or cancer is currently unclear [50]. 
The results of the present study also confirmed previous findings [10,11],regarding 
the existence of severe hypovitaminosis D between Orthodox monks. A potential 
explanation for the aforementioned observation is the fact that persons under religious 
order have to wear black cassocks during their outdoor activities; thus, this can have a 
negative impact on their vitamin D status. Comparable findings have been previously 
reported in other populations of the Mediterranean region, in whom, cutaneous 
vitamin D production is affected by clothing preference [51,52]. 
Our study presents specific limitations. The number of included subjects was 
relatively small; however, we consider that it was representative, since the monk’s 
community in Athos follows a common dietary and physical activity plan. The present 
analysis has not taken into account the seasonal changes in vitamin D concentrations, 
given that relative data from summer months is missing. Finally, this is a cross-
sectional study and thus unable to establish causal associations. 
In conclusion, this study offers - for the first time - detailed appraisal of COF as 
practiced in Mount Athos, in a comparative evaluation with the typical COF as 
practiced by the general Orthodox population. Its results highlight the unique 
characteristics of Athonian fasting and its value as a health-promoting diet.  
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We consider that the positive impact of this nutritional model on human homeostasis 
is facilitated by a variety of valuable mechanisms, extended beyond the benefits of a 
typical vegetarian diet. These mechanisms mainly include caloric restriction, 
combined with augmented intake of high nutritional quality, organic foods, mostly 
produced by the monks themselves within the community of Mount Athos, and thus 
being free of genetically modified ingredients. Future trials are necessary in order to 
investigate the role of COF as medical nutrition therapy for chronic metabolic 
diseases and the potential effects of limited intake of specific vitamins and minerals 
during fasting. 
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Abbreviations: y: years; kg: kilograms; cm: centimetres; BMI: Body Mass Index; BF: Body fat; VF: 
Visceral fat; WC: Waist Circumference; FFM: Fat-free mass; MM: Muscle mass; TBW: Total body 
water; BMR: Basal metabolic rate 
  
Table 1:Demographic and anthropometric parameters of the two groups 
Parameter 
Group 1 
General population fasters 
Group 2 
Athonian monks 
P-value 
Sex Males (N=43) Males (N=57) - 
Age (y) 38.52 ± 11.44 38.82 ± 10.16 p=.170 
Years at Mt. Athos (y) - 12.69 ± 8.41 - 
Years of monasticism 
(y) 
- 13.27 ±8.19 - 
Weight (kg) 91.27 ± 13.46 74.2 ± 12.35 p<.001 
Height (cm) 178.07 ± 6.24 176.69 ± 3.25 p=.160 
BMI 28.92 ± 4.50 23.77 ± 3.91 p<.001 
BF (%) 26.04 ± 8.18 18.33 ± 8.34 p<.001 
BF (kg) 24.61 ± 11.18 14.57 ± 8.98 p=.001 
VF (kg) 13.49 ± 5.87 7.08 ± 4.50 p<.001 
WC (cm) 94.32 ± 3.32 83.26 ± 4.23 p<.001 
FFM (kg) 66.63 ± 5.50 59.76 ± 6.07 p<.001 
MM (kg) 59.38 ± 5.30 33.31 ± 4.54 p<.001 
TBW % 54.24 ± 6.01 60.01 ±6.21 p<.001 
TBW kg 48.87 ± 3.99 43.94 ± 4.41 p<.001 
BMR kcal 1810.09 ±118.59 1661.88 ± 131.07 p<.001 
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Table 2: Dietary and nutrient intakes on RD and NRD in the general population fasters group 
Intake Restrictive Day (RD) Non-Restrictive Day (NRD) Test Statistics 
Energy (kcal) 1575.5 ± 285.96 2137.8 ± 470.84 t(23)= -6.657, d = -1.473, r= 0.491, p < .001 
Carbohydrates (g) 235.20 ± 71.49 176.94 ± 51.19 t(23)= 3.339, d = 0.688, r = 0.047, p= .003 
%TEI 59.9 ± 14.4 32.97 ± 6.24 Z = -4.229, p < .001 
Fat (g) 54.94 ± 26.92 104.59 ± 31.22 t(23)= -5.985, d = -1.19, r = 0.028, p < .001 
%TEI 31.0 ± 13.71 44.58 ± 9.23 Z = -3.029, p = .002 
Protein (g) 48.58 ± 15.98 98.01 ± 21.81 t(23)= -10.008, d = -2.04, r = 0.209, p < .001 
%TEI 12.4 ± 3.84 18.79 ± 4.63 Z = -4.143, p < .001 
Saturated fat (g) 10.36 ± 8.13 34.97 ± 14.70 t(23)=-7.650, d = -1.628, r = 0.142, p < .001 
Cholesterol (mg) 64.04 ± 145.90 372.21 ± 175.25 t(23)=-6.497, d = -1.331, r = -0.039, p<.001 
Fiber (g) 38.74 ± 16.49 19.84 ± 10.87 t(23)=4.554, d = 0.946, r = -0.066, p < .001 
Ca (mg) 484.69 ± 263.02 887.61 ± 411.14 t(23)=-3.667, d = -0.76, r = -0.238, p = .002 
%DRI 48.47 ± 26.31 86.02 ± 41.30 Z = -3.072, p = .002 
Fe (mg) 16.54 ± 6.02 13.45 ± 4.68 t(23)=1.822, d = 0.368, r = -0.193, p = .079 
%DRI 165.43 ± 60.20 135.47 ± 46.99 Z = -1.642, p = .101 
Mg (mg) 283.63 ± 130.77 240.90 ± 98.08 t(23)=1.367, d = 0.283, r = 0.127, p = .208 
%DRI 67.53 ± 31.14 58.02 ± 22.97  Z = -1.095, p = .274 
Na (mg) 1767.56 ± 1007.20 3224.33 ± 1184.78 t(23)=-4.113, d = -1.074, r = 0.234, p= .001 
%DRI 73.65 ± 41.97 130.90 ± 51.88 Z = -3.102, p = .002 
K (mg) 2575.82 ± 1065.56 2790.70 ± 982.00 t(23)=-0.841, d = -0.169, r = 0.231, p = .438 
%DRI 68.59 ± 28.41 74.85 ± 25.77 Z = -0.639, p = .523 
Vit A (mcg) 732.90 ± 817.94 1209.66 ± 1245.59 t(23)=-1.564, d = -2.435, r = 0.982, p = .162 
%DRI 73.29 ± 81.80 121.81 ± 124.57 Z = -2.007, p = .045 
Vit B12 (mcg) 1.06 ± 1.63 5.61 ± 4.95 t(23)=-5.165, d = -0.982, r = 0.008, p <.001 
%DRI 44.36 ± 67.75 227.92 ± 211.26 Z = -3.848, p < .001 
Vit B2 (mcg) 1.10 ± 0.38 1.75 ± 0.43 t(23)=-5.176, d = -1.420, r = 0.361, p <.001 
%DRI 84.23 ± 29.01 132.92 ± 34.93 Z = -3.650, p < .001 
Vit C (mcg) 119.88 ± 94.00 103.93 ± 94.74 t(23)=0.763, d = 0.112, r = 0.046, p = .523 
%DRI 199.79 ± 156.66 173.41 ± 157.77 Z = -0.517, p = .605 
Vit D (mcg) 0.60 ± 1.09 3.14 ± 3.82 t(23)=-3.057, d = -1.213, r = 0.636, p = .006 
%DRI 11.97 ± 21.78 60.36 ± 77.38 Z = -3.255, p = .001 
Vit E (mcg) 8.31 ± 4.45 9.16 ± 4.25 t(23)=-0.680, d = -0.606, r = 0.948, p = .551 
%DRI 83.10 ± 44.56 92.09 ± 42.03 Z = -0.821, p = .412 
 
 
Abbreviations: %DRI, percentage of the dietary reference intake; %TEI, percentage of the daily total 
energy intake 
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a
 The correlation coefficient (r) and t-test statistics (t) cannot be computed because the 
standard error of the difference is 0. Z denotes Wilcoxon-signed rank test statistics with P-value for 
exact significance (two-tailed). 
b
 Effect size cannot be calculated because of the uniform s.d. and/or 
perfect correlation. 
Table 3:  Dietary and nutrient intakes on RD and NRD for Athonian monks. 
 
Intake Restrictive Day (RD) Non-Restrictive Day (NRD) Test Statistics 
Energy (kcal) 1362.42 ± 84.52  1571.55 ± 81.07 t(69)= -24.146, d = -2.890, r = 0.618, p < .001 
Carbohydrates (g) 159.6 ± 21.82 294.35 ± 23.40 t(69)= -54.777, d = -6.565, r = 0.588, p < .001 
%TEI 46.64 ± 3.41  74.95 ± 2.43 Z = -7.300, p < .001 
Fat (g) 30.07 ± 0.17 21.47 ± 1.96 t(69)= 37.412, d = 7.66, r = 0.396, p < .001 
%TEI 19.93 ± 1.09 12.28 ± 0.63 Z = -7.300, p < .001 
Protein (g) 89.24 ± 1.38 72.35 ± 1.32 t(69)= 119.795, d = 14.315, r = 0.618, p < .001 
%TEI 26.28 ± 1.19 18.47 ± 0.56 Z = -7.300, p < .001 
Saturated fat (g) 
a,b
 12.75 ± 0.00 16.40 ± 0.00 - 
Cholesterol (mg)
 a,b
 181.00 ± 0.00 178.00 ± 0.00 - 
Fiber (g) 23.42 ± 0.93 36.22 ± 0.89 t(69)= -449.592, d = -60.530, r = 0.973, p < .001 
Ca (mg) 579.51 ± 2.29 665.69 ± 2.27 
t(69)= -2260.844, d = -267.274, r = 0.990, p < 
.001 
%DRI 57.94 ± 0.23 66.56 ± 0.22 Z = -7.649, p < .001 
Fe (mg) 13.70 ± 0.00 18.13 ± 0.06 t(69)= -619.482, p < .001 
%DRI 137.00 ± 0.00 181.30 ± 0.60 Z = -7.722, p < .001 
Mg (mg) 167.43 ± 3.29 152.29 ± 3.14 t(69)= 621.927, d = 105.300, r = 0.999, p < .001 
%DRI 39.84 ± 0.77 36.23 ± 0.74 Z = -7.451, p < .001 
Na (mg)
 a,b
 1733.00 ± 0.00 1549.00 ± 0.00 - 
%DRI
 a,b
 72.21 ± 0.00 64.54 ± 0.00 - 
K (mg) 2539.00 ± 88.56 3755.59 ± 88.67 t(69)= -20515.135, d = 0.00, r = 1.00, p < .001 
%DRI 67.63 ± 2.34 100.07 ± 2.34 Z = -7.526, p < .001 
Vit A (mcg) 805.64 ± 24.26 708.26 ± 24.46 t(69)= 1936.152, r = 1.00, p < .001 
%DRI 80.48 ± 2.40 70.74 ± 2.42 Z = -7.414, p < .001 
Vit B12 (mcg)
 a,b
 5.50 ± 0.00 5.60 ± 0.00 - 
%DRI
 a,b
 229.17 ± 0.00 233.33 ± 0.00 - 
Vit B2 (mcg) 1.01 ± 0.02 1.11 ± 0.02 t(69)= -99.901, d = -20.412, r = 0.970, p < .001 
%DRI 77.44 ± 1.76  85.41 ± 1.26 Z = -7.475, p < .001 
Vit C (mcg) 257.54 ± 2.99 373.78 ± 2.91 
t(69)= -3868.426, d = -508.696, r = 0.997, p < 
.001 
%DRI 429.04 ± 622.79 622.79 ± 4.79 Z = -7.507, p < .001 
Vit D (mcg)
 a,b
 1.00 ± 0.00 0.98 ± 0.00 - 
%DRI
 a,b
 20.00 ± 0.00 19.60 ± 0.00 - 
Vit E (mcg)
 a,b
 5.70 ± 0.00 13.80 ± 0.00 - 
%DRI
 a,b
 57.00 ± 0.00 138.00 ± 0.00 - 
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Abbreviations: %DRI, percentage of the dietary reference intake; %TEI, percentage of the daily total 
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Abbreviations: %DRI, percentage of the dietary reference intake; %TEI, percentage of the daily total 
energy intake 
 
 
  
Table 4: Dietary and nutrient intakes of general population fasters and Athonian Monks on Restrictive Day 
  
Intake 
Group 1 
General population fasters 
Group 2 
Athonian monks Test Statistics 
Energy (kcal) 1575.47 ± 285.96 1362.42 ± 84.52 t(92)= 5.607, d = 1.150, p < .001 
Carbohydrates (g) 235.20 ± 71.49 159.60 ± 21.82 t(92)= 7.905, d = 1.620, p < .001 
%TEI 60.3 ± 18.5 46.64 ± 3.41 Z = -4.792, p < .001 
Fat (g) 54.94 ± 26.92 30.07 ± 0.18 t(92)= 7.809, d = 1.835, p < .001 
%TEI 30.5 ± 15.0 19.93 ± 1.09 Z = -3.634, p < .001 
Protein (g) 48.58 ± 15.99 89.24 ± 1.38 t(92)= -21.268, d = -4.682, p < .001 
%TEI 12.5 ± 4.1 26.28 ± 1.19 Z = -7.224, p < .001 
Saturated fat (g) 10.36 ± 8.13 12.75 ± 0.00 t(92)= -2.484, d = -0.294, p = .015 
Cholesterol (mg) 64.04 ± 145.90 181.00 ± 0.00 t(92)= -6.778, d = -0.802, p < .001 
Fiber (g) 38.74 ± 16.49 23.42 ± 0.93 t(92)= 7.818, d = 1.759, p < .001 
Ca (mg) 484.69 ± 263.02 579.51 ± 2.29 t(92)= -3.048, d = -0.715, p = .003 
%DRI 48.60 ± 26.88 57.94 ± 0.23 Z = -4.088, p < .001 
Fe (mg) 16.53 ± 6.02 13.7 ± 0.00 t(92)= 3.993, d = 0.470, p < .001 
%DRI 167.30 ± 60.84 137.00 ± 0.00 Z = -4.527, p < .001 
Mg (mg) 283.63 ± 130.77 167.43 ± 3.29 t(92)= 7.506, d = 1.734, p < .001 
%DRI 67.34 ± 31.82 39.84 ± 0.77 Z = -4.303, p < .001 
Na (mg) 1767.56 ± 1007.20 1733.00 ± 0.00 t(92)= 0.290, d = 0.034, p = .772 
%DRI 74.91 ± 42.78  72.21 ± 0.00  Z = -0.412, p = .524 
K (mg) 2575.82 ± 1065.56 2539.00 ± 88.56 t(92)= 0.289, d = 0.064, p = .773 
%DRI 69.08 ± 28.99 67.63 ± 2.34 Z = -0.638, p = .524 
Vit A (mcg) 732.90 ± 817.94 805.64 ± 24.26 t(92)= -0.751, d = -0.173, p = .455 
%DRI 75.13 ± 83.12 80.48 ± 2.40 Z = -0.702, p = .004 
Vit B12 (mcg) 1.06 ± 1.63 5.50 ± 0.00 t(92)= -23.064, d = -2.724, p < .001 
%DRI 45.33 ± 69.10 229.17 ± 0.00 Z = -8.642, p < .001 
Vit B2 (mcg) 1.10 ± 0.38 1.01 ± 0.02 t(92)= 1.949, d = 0.450, p = .054 
%DRI 85.25 ± 29.22 77.44 ± 1.76 Z = -0.709, p = .478 
Vit C (mcg) 119.88 ± 94.00 257.54 ± 2.99 t(92)= -12.364, d = -2.839, p < .001 
%DRI 200.33 ± 160.16 429.04 ± 4.95 Z = -6.010, p < .001 
Vit D (mcg) 0.60 ± 1.09 1.00 ± 0.00 t(92)= -3.119, d = -0.367, p = 0.002 
%DRI 12.41 ± 22.16 20.00 ± 0.00 Z = -8.642, p < .001 
Vit E (mcg) 8.31 ± 4.45 5.71 ± 0.30 t(92)= 4.914, d = 1.095, p < .001 
%DRI 80.77 ± 43.93 57.00 ± 3.00 Z = -3.135, p = .002 
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Abbreviations: %DRI, percentage of the dietary reference intake; %TEI, percentage of the daily 
total energy intake 
 
 
  
Table 5:  Dietary and nutrient intakes of general population fasters and Athonian Monks on Non-restrictive Day 
  
Intake 
Group 1 
General population fasters 
Group 2 
Athonian monks Test Statistics 
Energy (kcal) 2137.80 ± 470.84 1571.55 ± 81.07 t(92)= 9.744, d = 2.052, p < .001 
Carbohydrates (g) 176.63 ± 51.19 294.35 ± 23.40 t(92)= -15.243, d = -3.156, p < .001 
%TEI 33.39 ± 6.03 74.95 ± 2.43 Z = -7.236, p < .001 
Fat (g) 104.59 ± 31.22 21.47 ± 1.96 t(92)= 22.378, d = 5.010, p < .001 
%TEI 43.95 ± 9.27 12.28 ± 0.63 Z = -7.236, p < .001 
Protein (g) 98.01 ± 21.81 72.35 ± 1.32 t(92)= 9.894, d = 2.219, p < .001 
%TEI 18.84 ± 4.73 18.47 ± 0.56 Z = -0.989, p = .323 
Saturated fat (g) 34.97 ± 14.70 16.40 ± 0.00 t(92)= 10.678, d = 1.263, p < .001 
Cholesterol (mg) 372.21 ± 175.25 178.00 ± 0.00 t(92)= 9.370, d = 1.108, p < .001 
Fiber (g) 19.84 ± 10.87 36.22 ± 0.89 t(92)= -12.617, d = -2.786, p < .001 
Ca (mg) 887.61 ± 411.14 665.69 ± 2.27 t(92)= 4.564, d = 1.074, p < .001 
%DRI 85.82 ± 42.22 66.56 ± 0.22 Z = -3.045, p = .002 
Fe (mg) 13.45 ± 4.68 18.13 ± 0.06 t(92)= -8.442, d = -1.975, p < .001 
%DRI 135.83 ± 48.02 181.30 ± 0.60 Z = -5.914, p < .001 
Mg (mg) 240.92 ± 98.08 152.29 ± 3.14 t(92)= 7.627, d = 1.751, p < .001 
%DRI 57.94 ± 23.48 36.23 ± 0.74 Z = 5.345, p < .001 
Na (mg) 3224.33 ± 1184.78 1549.00 ± 0.00 t(92)= 11.956, d = 1.414, p < .001 
%DRI 131.04 ± 53.04 64.54 ± 0.00 Z = -6.996, p < .001 
K (mg) 2790.70 ± 982.00 3755.59 ± 88.87 t(92)= -8.208, d = -1.802, p < .001 
%DRI 75.16 ± 26.30 100.07 ± 2.34 Z = -5.435, p < .001 
Vit A (mcg) 1209.66 ± 1245.59 708.26 ± 24.46 t(92)= 3.402, d = 0.790, p = .001 
%DRI 122.04 ± 127.47 70.74 ± 2.42 Z = -2.134, p = .033 
Vit B12 (mcg) 5.62 ± 4.95 5.60 ± 0.00 t(92)= 0.029, d = 0.004, p = .977 
%DRI 231.18 ± 215.18 233.33 ± 0.00 Z = -2.058, p = .040 
Vit B2 (mcg) 1.75 ± 0.43 1.11 ± 0.02 t(92)= 12.656, d = 2.844, p < .001 
%DRI 133.11 ± 35.71 85.41 ± 1.26 Z = -6.052, p < .001 
Vit C (mcg) 103.93 ± 94.74  373.78 ± 2.91 t(92)= -24.048, d = -5.527, p < .001 
%DRI 176.98 ± 160.32 622.78 ± 4.79 Z = -7.232, p < .001 
Vit D (mcg) 3.14 ± 3.82 0.98 ± 0.00 t(92)= 4.787, d = 0.565, p < .001 
%DRI 62.33 ± 78.50 19.60 ± 0.00 Z = -3.704, p < .001 
Vit E (mcg) 9.16 ± 4.25 13.81 ± 0.30 t(92)= -9.191, d = -2.044, p < .001 
%DRI 89.18 ± 40.43 138.00 ± 3.00 Z = -4.707, p < .001 
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Abbreviations: CRP: C-Reactive protein; ALT: alanine transaminase; AST: aspartate transaminase; 
CHOL: total cholesterol; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein 
cholesterol; PTH: parathyroid hormone; TRIG: triglycerides; 25(OH)D: 25-hydroxyvitamin-D; 
HOMA-IR: Homeostatic Model Assessment for Insulin Resistance 
 
 
 
 
Table 6:  Cardiometabolic markers in general population fasters and Athonian Monks 
Biochemical 
Marker 
Group 1 
General population fasters 
Group 2 
Athonian monks Test Statistics 
CRP (mg/dl) 0.37 ± 0.61 - - 
CHOL (mg/dl) 189.1 ± 45.08 183.00 ± 40.87 t(99.758)= 0.725, d = 0.142, p = .470 
TRIG (mg/dl) 113.22 ± 79.09 73.82 ± 31.68 t(105)= 3.460, d = 0.711, p = .001 
HDL (mg/dl) 43.20 ± 11.05 47.83 ± 14.11 t(103.733)= -1.898, d = -0.368, p = .061 
LDL (mg/dl) 120.68 ± 45.92 119.97 ± 36.70 t(93.582)= 0.088, d = 0.017, p = .930 
Calcium (mg/dl) 9.01 ± 1.27 9.06 ± 0.42 t(112)= -0.270, d = -0.059, p = .788 
Phosphor (mg/dl) 3.58 ± 0.86 - - 
Insulin (µg/ml) 11.64 ± 9.21 4.61 ± 3.16 t(100)= 5.150, d = 1.137, p < .001 
PTH (pg/ml) 37.69 ± 16.36 116.09 ± 49.75 t(110)= -11.283, d = -2.372, p < .001 
1250H2D2 27.93 ± 36.00 - - 
1a250H2D3 5018.50 ± 2158.22 - - 
25(OH)D2 32.34 ± 39.51 - - 
25(OH)D (ng/ml) 28.26 ± 39.66 9.27 ± 5.81 t(103)= 3.448, d = 0.839, p = .001 
Glucose (mmol/l) 5.12 ± 0.32 4.71 ± 0.60 t(114)= 4.645, d = 0.891, p <.001 
Uric Acid (mg/dl) - 4.72 ± 0.90  - 
AST UL - 28.37 ± 13.64 - 
ALT UL - 26.04 ± 9.31  - 
HOMA-IR 
(mmol/l) 2.67 ± 2.19 0.98 ± 0.72 t(100)= 5.229, d = 1.162, p < .001 
Ferritin (ng/ml) - 77.65 ± 37.92 - 
